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Abstract The present study was designed to investigate the role
ofpostnatal fluoride intakeon [3H]glucoseuptakeand transport in
rat brain and peripheral tissues. Sodium fluoride (NaF) in a
concentration of 10 or 50 ppm was added to the drinking
water of adult Wistar rats. The control group received distilled
water. After 4 weeks, respective plasma fluoride levels were
0.0541 ± 0.0135 μg/ml (control), 0.0596 ± 0.0202 μg/ml
(10 ppm), and 0.0823 ± 0.0199 μg/ml (50 ppm). Although
plasma glucose levels were not altered in any group, the plasma
insulin level in the fluoride (50 ppm) group was elevated
(0.72 ± 0.13 μg/ml) versus the control group (0.48 ± 0.24μg/ml)
and fluoride (10ppm)group. In rats receiving fluoride for 4weeks
at 10 ppm in drinkingwater, [3H]glucose uptakewas unaltered in
all tested parts of the brain. However, in rats receiving fluoride at
50ppm, [3H]glucoseuptake in cerebral cortex, hippocampus, and
thalamuswithhypothalamuswaselevated,versusthesalinegroup.
Fluoride intake had a negligible effect on [3H]glucose uptake by
peripheral tissues (liver,pancreas, stomach,small intestine,atrium,
aorta, kidney, visceral tissue, lung, skin, oral mucosa, tongue, sal-
ivary gland, incisor, molars, and jawbone). In neither fluoride
group was glucose transporter proteins 1 (GLUT 1) or 3 (GLUT
3) altered in frontal cortex and striatum versus control. On the
assumption that increased glucose uptake (by neural tissue) rea-
sonablyreflectsneuronalactivity, itappearsthatfluoridedamageto
the brain results in a compensatory increase in glucose uptake and
utilizationwithout changes inGLUT 1 andGLUT3 expression.
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Introduction
Fluorine, an abundant element in the earth crust, readily reacts
with other elements to produce salts known as fluorides.
Ground water becomes contaminated at fluoride levels rang-
ing from 1.0 to more than 600 mg/l depending on the area of
study (WHO 2006; Brindha and Elango 2011). For humans,
drinking water is the largest contributor to the daily fluoride
intake although it is also present in vegetables, fruits, black
tea, and fish bones. Thus, the consumption of food and bev-
erages made with fluoridated water is one source of natural
intake of this element, but consumption of ordinary drinking
water is the main source. Fluoride is also found in dusts, in-
dustrial wastes, and burning of coal. Additional routes of ex-
posure are inadvertent ingestion of toothpaste (young chil-
dren) and use of fluoridated dental products (i.e., mouth rinses,
dental floss) (Jha et al. 2011).
Fluoride in low amount (0.5–1.5 mg/l) has remarkable pro-
phylactic effects in inhibiting dental caries while at higher
doses it causes dental and skeletal fluorosis. However, harm-
ful effects of excess fluoride intake are also observed in soft
tissues like liver, kidney, and brain. From animal studies, we
have learned that fluoride crosses the blood–brain barrier and
accumulates in the brain. Neurotoxicity caused by chronic
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fluoride exposure in rats results in a marked increase in oxi-
dative stress, lipid peroxidation, and a decrease in the activity
of antioxidant enzymes in discrete brain regions (Flora et al.
2009; Ranpariya et al. 2011). Also, alterations in activity of
the neurotransmitters and their metabolism (e.g., decrease in
nicotinic acetylcholine receptors or norepinephrine (NE) and
5-hydroxytryptamine (5-HT) increase) is associated with
memory impairment that outlasts short-term fluoride in labo-
ratory animals (Pereira et al. 2011). Consequently, neurologi-
cal symptoms, including reduced intelligence quotient in chil-
dren, cognition andmemory impairment with decreased learn-
ing ability have been reported in fluoride-polluted areas (Choi
et al. 2012).
Another biochemical hallmark of fluoride exposure in
mammals is impairment in glucose metabolism (Perumal
et al. 2013) which is the obligate energetic fuel for the central
nervous system (CNS) as well as the only substrate able to
completely sustain neural activity. The brain glucose level
represents a net balance of glucose uptake from circulation),
glucose metabolism to lactate and CO2, and glucose transport
back to the circulation (Sandoval et al. 2008). Nutrients are
transported across cellular membranes by specific glucose
transporters (GLUTs) and monocarboxylate transporters
(MCTs). The transport of glucose into mammalian cells is
mediated by the 13 different GLUT proteins, of which
GLUT1 and GLUT3 are most abundantly expressed in the
brain (Jurcovicova 2014). In recent years, many studies have
indicated that abnormalities in glucose metabolism may affect
cognitive functions, e.g., patients with Alzheimer’s disease
display a specific pattern of low brain glucose metabolism
relative to healthy controls, with additional reduced expres-
sion of GLUT and insulin receptors in the brain (Mooradian
et al. 1997; Cunnane et al. 2010). These findings implicate
impaired insulin signaling in the cognitive deficits in
Alzheimer disease (Steen et al. 2005). Moreover, it was re-
cently shown that MCT1 function in oligodendrocytes is es-
sential to prevent neurodegeneration, indicating the potential
involvement of nutrient transporters in the development and
progression of other neurological disorders as well (e.g.,
amyotrophic lateral sclerosis) (Lee et al. 2012).
Data on fluoride exposure and glucose metabolism impair-
ments in mammals are rather fragmentary: (1) chronic fluoride
exposure results in hyperglycemia accompanying classical
symptoms of fluorosis, with diabetogenic effect of fluoride
deriving from inhibition of key enzymes in glycolysis and in
the Krebs cycle (Grucka-Mamczar et al. 2007); (2) a recent
study also indicates that fluoride exposure lowers insulin se-
cretion, consequent to a reduction in insulin mRNA and its
secretion from beta-cells). This may account for increased
blood glucose levels in fluoride intoxicated animals (Garzia-
Montalvo et al. 2009); and (3) developmental fluoride expo-
sure causes neuronal degeneration, decreased brain glucose
utilization, and decreased the protein expression of GLUT 1
with concomitant impairment in learning and memory
through adulthood (Jiang et al. 2014).
The current study was conducted in order to assess the
effects of fluoride exposure on the [3H]glucose uptake in the
brain of adult Wistar rats. Because other tissues are also es-
sential in the overall schema of fluoride effects on glucose
metabolic abnormalities, we additionally assessed
[3H]glucose uptake by peripheral tissues.
Materials and Methods
Animals and Treatment
Adult (age, 8 weeks) male and female Wistar rats weighing
200–250 g were obtained from the University Animal
Department (Katowice, Poland) and were housed in a well-
ventilated room, at 22 ± 2 °C under a 12-h light to:12-h dark
cycle (lights on 7:00 a.m. to 7:00 p.m.), and with free access to
food and water. Starting at 9 weeks sodium fluoride (NaF), 10
or 50 ppm, was added to drinking water for 4 weeks (exposure
time). Control rats consumed tap water. On the last day of
exposure, rats were transferred for further experimentation.
All procedures were approved by the Local Bioethical
Committee for Animal Care, Medical University of Silesia
(permission no 62/2011 issued on 2011.09.14) and are in ac-
cord with principles and guideline described in the NIH book-
let BCare and Use of Laboratory Animals.^
Analysis of Blood Fluoride Level
Fluoride concentration in urine was measured directly with an
ion selective electrode (Orion 94–09, Orion Research, MS,
USA) after the addition of TISAB II (Orion Research).
Analysis of Blood Glucose Level
On the last day of exposure, rats of all groups (control, NaF
10 ppm and NaF 50 ppm) were sacrificed and trunk blood was
taken for plasma glucose and insulin analysis. All samples
were promptly centrifuged, and the sera were separated and
stored at −20 °C until the time of analysis. Blood glucose
levels were measured by the glucose oxidase-peroxidase
method with automated clinical chemistry analyzer - Optium
Omega (Abbott, Alameda, USA). Data were expressed in mil-
ligrams per milliliter (Kitamura et al. 2009).
Analysis of Blood Insulin Level
Commercially available enzyme-linked immunosorbent assay
kits (ELISA) were used (according to the manufacturer’s in-
structions) to determine insulin levels (Insulin LND,
Germany). The absorbance measurements for all samples
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were performed using the Universal Micropla te
Spectrophotometer (μQUANT BIOTEK Instruments, Inc.,
Winooski, VT, USA) at 450 nm. Assay sensitivity for insulin
was 15 μg/l; the intra- and interassay CVs were −4.6 and
6.5%, respectively (Rakatzi et al. 2004).
6-[3H]-D-Glucose Uptake
On the last day of exposure, rats were injected i.p. with 6-[3H]-
D-glucose (Amersham Radiochemicals, Pittsburgh, PA, USA;
41 Ci/mmol; 0.5 μCi/g BW). After 15 min, rats were
sacrificed and the frontal cortex, hippocampus, striatum, and
thalamus with hypothalamus were dissected. The lungs, kid-
ney, spleen, stomach muscle, jejunum, visceral adipose tissue,
liver, femoral muscle, heart muscle, atrium, aorta, femoral
bone, skin, oral mucosa, tongue, parotid gland, incisors, molar
tooth, and mandible also were taken as samples for determi-
nation of radioactivity in a liquid scintillation counter. Each
tissue sample was weighed and placed in a 20-ml scintillation
vial containing 1 ml of Soluene-350 (Packard Inc., Downers
Grove, Ill., USA). Each vial was then tightly sealed and incu-
bated at 37 °C for 48 h, to solubilize tissue. Later, scintillation
cocktail (10 ml, Dimilume-30, Packard Inc., Downers Grove,
Ill., USA) was added, and the vials were briefly vortexed
before being placed in a scintillation counter (Liquid
Scintillation Counter, DSA 1409, Wallac, Finland). Results
are expressed as disintegrations per minute (DPM) per
100 mg of wet tissue (mean ± SEM) for each group
(Konecki et al. 2006).
Immunohistochemistry and Densitometric Analysis
of GLUT 1 and GLUT 3
Immunostaining for GLUT 1 and GLUT 3 protein expression
was carried out according to Kuter et al. (2011). At 12 weeks
of age (4weeks NaF exposure) rats were decapitated, the brain
was rapidly removed, postfixed in cold 4% paraformaldehyde
for 7 days, and cryoprotected in 20% sucrose solution in
phosphate-buffered saline (PBS). The brains were sectioned
(30 μm frontal sections) on a freezing microtome
(AP = 2.52 mm from bregma according to Paxinos and
Watson (2007)). Free-floating sections were incubated for
48 h at 4 °C in primary antibodies (anti-CB1 receptor,
1:1000; Sigma, Germany), rinsed in PBS, then incubated for
30 min in secondary antibodies (anti rabbit biotinylated,
1:200, Vector Laboratories, UK) and processed using an
ABC-peroxidase kit (Vector Laboratories, UK) and 3,3′-di-
aminobenzidine as a chromogen. Stained sections were
mounted on slides, dried, dehydrated, cleared in xylene, and
cover-slipped in a Permount medium (Fisher Scientific,
USA).
Two sections stained immunohistochemically for GLUT 1
and GLUT 3 protein were analyzed densitometrically in the
region of striatum and frontal cortex. All sections were
scanned together, digitalized, adjusted for brightness, and re-
gions of interest outlined using Multi Gauge programme
(FUJIFILM). Optical density (OD) for each area was then
determined. Background signal was subtracted from each sec-
tion separately, from the region of corpus callosum. Results
are presented as mean of each OD/area2 minus background.
Data Analysis
Two-way analysis of variance (ANOVA) and the post-
ANOVA test of Neuman-Keuls were used to test differences
between groups. A p value of 0.05 or less was used to indicate
a significant difference.
Results
Fluoride Intake and Fluoride Plasma Assay
In the present work, we observed that control rats consumed
an average of 170.3 ml/kg/24 h tap water, whereas rats treated
with NaF 10 or 50 ppm consumed an average of 200.6 ml/kg/
24 h or 215.7 ml/24 h, respectively—leading to the intake of
2.11 and 11.43 mg/kg/24 h of fluoride, respectively. After
multiplication by 28 days (exposure time), the cumulative
amounts of fluoride consumption were 59.8 mg/kg (10 ppm)
and 320.04 mg/kg (50 ppm).
Plasma fluoride levels after 30 days of drinking fluoridated
water were significantly (p < 0.05) higher in the group ex-
posed to NaF 50 ppm (0.0823 ± 0.0199 μg/ml) in comparison
to control (0.0541 ± 0.0135 μg/ml) and NaF 10 ppm
(0.0596 ± 0.0202 μg/ml) (Fig. 1).
Glucose and Insulin Blood Assay
Plasma glucose concentration did not significantly differ
among the experimental groups (ANOVA, p > 0.05), i.e., con-
trol—75.75 ± 8.17 mg/dl; fluoride (10 ppm)—77.13 ± 10.0;
fluoride (50 ppm)—80.75 ± 11.88 mg/dl. However, plasma
insulin levels were significantly higher as fluoride concentra-
tion increased in drinking water, attaining significance be-
tween control (0.48 ± 0.24 μg/ml) and fluoride (50 ppm)
groups (0.72 ± 0.13 μg/ml) (ANOVA, Neuman-Keuls post-
test, p < 0.05) (Fig. 2).
[3H]Glucose Uptake in the Brain
In rats exposed to 10 ppm NaF, [3H]glucose uptake was unal-
tered in all tested parts of the brain. However, in rats exposed
to 50 ppm NaF, [3H]glucose uptake in cerebral cortex, hippo-
campus, and thalamus with hypothalamus was elevated,
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versus the saline group (ANOVA, Neuman-Keuls post-test,
p < 0.05) (Fig. 3).
[3H]Glucose Uptake in Peripheral Tissues
NaF intake had negligible effects on [3H]glucose uptake by
peripheral tissues (liver, pancreas, stomach, small intestine,
atrium, aorta, kidney, visceral tissue, lung, skin, oral mucosa,
tongue, salivary gland, incisor, molars, and jawbone). Only in
rats exposed to NaF (10 ppm) there was a decrease in
[3H]glucose uptake in thigh muscle and femoral bone
(Table 1).
GLUT 1 and GLUT 3 in the Frontal Cortex and Striatum
Immunostaining for GLUT 1 and GLUT 3 protein expression
was carried out in the frontal cortex, demonstrating that there
were no significant changes among the experimental groups
(ANOVA, p > 0.05), i.e., GLUT 1 (control—37.98 ± 2.71 QL/
pixel2; fluoride (10 ppm)—35.13 ± 3.10 QL/pixel2; fluoride
(50 ppm)—39.31 ± 3.08 QL/pixel2), GLUT 3 (control—
23.80 ± 3.27 QL/pixel2; fluoride (10 ppm)—25.21 ± 3.25
QL/pixel2; fluoride (50 ppm)—24.60 ± 2.93 QL/pixel2)
(Fig. 4).
Immunostaining for GLUT 1 and GLUT 3 protein expres-
sion carried out in the striatum also showed no significant
changes among the experimental groups (ANOVA,
p > 0.05), i.e., GLUT 1 (control—47.80 ± 4.29 QL/pixel2;
fluoride (10 ppm)—43.78 ± 3.21 QL/pixel2; fluoride
(50 ppm)—50.21 ± 5.50 QL/pixel2), GLUT 3 (control—
25.18 ± 3.22 QL/pixel2; fluoride (10 ppm)—25.57 ± 4.11
QL/pixel2; fluoride (50 ppm)—24.76 ± 3.10 QL/pixel2)
(Fig. 5).
Discussion
The main finding of the present study is that fluoride expo-
sure, depending on the level of consumption, had qualitatively
different effects on [3H]glucose uptake in the brain of rats. A
low NaF concentration (10 ppm) failed to alter [3H]glucose
uptake in all examined brain regions while a higher NaF con-
centration (50 ppm) increased [3H]glucose uptake, in the ab-
sence of change in GLUT 1 and GLUT 3 protein density in the
brain. Alterations in [3H]glucose uptake by peripheral tissues
were negligible in rats exposed to 10 or 50 ppm NaF in drink-
ing water.
In contrast to peripheral effects of fluoride exposure, data
on fluoride neurotoxicity in mammals are rather fragmentary
and focused mainly on oxygen metabolism, the production of
O2
− free radicals and activities of some antioxidant enzymes
like superoxide dismutase (SOD), catalase and glutathione
Fig. 1 Fluoride intake and
plasma fluoride concentration in
adult rats exposed to NaF in
drinking water in a concentration
of 10 or 50 ppm (n = 8).
Control, NaF 10 ppm,
NaF 50 ppm; # indicates
p < 0.05
Fig. 2 Glucose and insulin
plasma concentrations in adult
rats exposed to fluoride in
drinking water in concentrations
of 10 or 50 ppm (n = 8).
Control, NaF 10 ppm,
NaF 50 ppm; # indicates
p < 0.05
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peroxidase (GPX) (Inkielewicz and Krechniak 2004;
Shanthakumari et al. 2004). Notably, fluoride crosses the
blood–brain barrier, to accumulate in hippocampal neuronal
cell bodies and initiate a cascade of reactions which increases
oxidative stress—the net effect being an elevation in
malondialdehyde (the end product of lipid peroxidation) and
an increase in damage to hippocampal neurons (Sharma et al.
2014). Bhatnagar et al. (2002) similarly demonstrated
degenerated nerve cell bodies in the CA3, CA4, and dentate
gyrus of hippocampus following NaF exposure in adult fe-
male mice. Thus, fluoride exposure, similarly to other neuro-
toxins, can cause overt damage to neuronal tissue. However,
in addition to the effect of NaF in shifting the balance between
free radical generation and antioxidant defense system, other
mechanisms should be also considered, e.g., impairments in
brain glucose metabolism—as we observed in the present
work. Others have reported alterations in glucose uptake and
utilization in the brain after other insults (Mehlhorn et al.
1998). Previously, we showed that in rats pre- and postnatally
intoxicated with manganese (Mn 10,000 ppm) and lesioned as
neonates with 6-hydroxydopamine (6-OHDA; an animal
model of Parkinson disease) remarkable changes in
[3H]glucose uptake in the brain were observed. More specif-
ically, low dose 6-OHDA (2 × 15 μg icv) increased
Table 1 [3H]glucose uptake in the in the peripheral tissues in adult rats exposed to NaF in drinking water, at a concentration of 10 or 50 ppm (n = 6)
Part of the body Control DPM/100 mg
of wet tissue
Postnatally exposed to NaF 10 ppm
DPM/100 mg of wet tissue
Postnatally exposed to NaF 50
ppm DPM/100 mg of wet tissue
Liver 84,586.10 ± 7041.30 85,120.50 ± 7302.20 84,985.80 ± 2195.10
Pancreas 103,751.50 ± 19,052.90 110,152.00 ± 13,013.40 103,074.10 ± 6475.00
Stomach 45,109.90 ± 1279.40 47,682.80 ± 5522.30 47,153.50 ± 2787.40
Small intestine 60,244.10 ± 4025.50 56,374.40 ± 3603.50 65,553.00 ± 2200.50
Atrium 35,428.23 ± 1456.00 28,428.06 ± 2596.90 29,095.17 ± 2729.70
Heart muscle (ventricle) 35,575.80 ± 1321.00 37,726.30 ± 2051.70 36,792.90 ± 2071.20
Aorta 45,431.90 ± 4284.40 44,336.90 ± 3987.80 50,011.40 ± 2954.70
Kidney 89,556.50 ± 3259.50 91,945.90 ± 5389.70 98,784.80 ± 1809.00
Visceral fat 26,534.60 ± 5417.40 31,368.00 ± 4846.30 29,589.60 ± 5046.80
Lung 44,353.80 ± 2321.80 37,213.70 ± 4855.50 43,908.30 ± 2613.80
Muscle of thigh 28,771.30 ± 2351.40 20,402.20* ± 1721.60 26,897.70 ± 1353.00
Femur 23,858.20 ± 1483.30 17,299.00* ± 771.80 20,755.10 ± 1125.20
Skin 31,567.20 ± 764.90 30,097.40 ± 3451.60 35,249.80 ± 1072.70
Oral mucosa 41,683.40 ± 1354.40 37,149.20 ± 3539.40 37,397.30 ± 1524.20
Tongue 39,714.20 ± 1753.20 38,993.20 ± 2426.90 40,654.10 ± 1591.50
Salivary gland 29,322.20 ± 2467.20 29,490.80 ± 2047.40 31,732.80 ± 1556.60
Incisor 4056.20 ± 521.70 3462.70 ± 187.60 3714.20 ± 670.90
Molars 16,468.50 ± 1670.20 12,848.60 ± 1457.50 13,424.90 ± 908.80
Jawbone 15,937.20 ± 739.20 14,490.70 ± 853.00 16,008.60 ± 1174.00
*p < 0.05
Fig. 3 [3H]glucose uptake in the
brain in adult rats exposed to NaF
in drinking water, at a
concentration of 10 or 50 ppm
(n = 6). Control,
NaF 10 ppm,
NaF 50 ppm; # indicates
p < 0.05
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[3H]glucose uptake in brain. In rats lesioned with a moderate
dose of 6-OHDA (2 × 30 μg icv), [3H]glucose uptake was
unaltered in control and Mn exposed rats, while high dose 6-
OHDA (2 × 67 μg icv) reduced [3H]glucose uptake in the
brain of Mn exposed rats versus control (Kwieciński and
Nowak 2009). On the premise that increased glucose uptake
(by neural tissue) reflects neuronal activity, the damage by low
dose 6-OHDA (mild insult) is the result of a compensatory
increase in glucose uptake and utilization, while high dose of
6-OHDAwith concomitant Mn (severe damage) overwhelms
the regenerative ability of neurons and/or glia. It is likely that
the type of changes (increase or decrease) as well as the inten-
sity of glucose uptake disturbance depends on the severity of
brain damage.
Because of a scarcity of data concerning the molecular
mechanism of fluoride on brain glucose uptake, transport,
and metabolism, it is difficult to account for the obtained
effects of NaF. As previously stated, glucose levels in brain
are a net balance between uptake, metabolism to lactate and
CO2, and transport back to the circulation. Glucose enters
cells mainly via GLUT 1 and GLUT 3, and several factors
are able to modify GLUT protein expression and functioning.
Handa et al. (2000) found in rats injected with ethanol (3 g/kg)
that there was a decrease in GLUT 1 and GLUT 3 number but
not in GLUT’s affinity in the brain (cortex). They also showed
that there was no reduction in brain glucose utilization.
Summing up, that study signifies that one must distinguish
between glucose transporter protein expression and its affinity.
In our study, immunostaining for GLUT 1 and GLUT 3 pro-
tein expression in the cortex and striatum was unaltered
among the experimental groups (control; NaF 10 and
50 ppm). We hypothesize that elevated brain glucose uptake
in rats exposed to NaF was brought about by an increase in
GLUT affinity. Jiang et al. (2014) found that GLUT 1 protein
expression was significantly decreased in the cerebral cortex
and the hippocampus of both male and female rats treated pre-
and postnatally with 25–100 mg/l NaF. By the small-animal
PET/CT scan, they also revealed that the GLUT 1 expression
corresponded with a low rate of glucose utilization in animals
treated with higher doses of NaF. That is, NaF decreased the
expression of GLUT 1, which then decreased brain glucose
absorption and induced neuronal developmental toxicity. This
report contrasts with our results but discrepancies may result
from different doses of fluoride ingestion, a remarkably ex-
tended period of exposure (pre- and postnatal, approx.
12 weeks). In another ontogenetic study by Verma and Guna
Sherlin (2002), there were reductions in serum levels of glu-
cose in offspring of dams that were given NaF (40 mg/kg)
orally from day 6 of gestation through the time of weaning
at day 21. Conversely, Lombarte et al. (2013) demonstrated
Fig. 4 GLUT 1 and GLUT 3
protein immunoreactivity,
assessed densitometrically in
frontal cortex slices of adult rats
exposed for 4 weeks to NaF in
drinking water in a concentration
of 10 or 50 ppm (n = 7).
Control, NaF 10 ppm,
NaF 50 ppm; # indicates
p < 0.05
Fig. 5 GLUT 1 and GLUT 3
protein immunoreactivity,
assessed densitometrically in
striatum slices of adult rats
exposed for 4 weeks to NaF in
drinking water in a concentration
of 10 or 50 ppm (n = 7).
Control, NaF 10 ppm,
NaF 50 ppm; # indicates
p < 0.05
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that in rats given NaF (15 mg/l) in drinking water there was a
significant plasma increase in glucose level and insulin resis-
tance. Others have shown an increase of serum insulin and a
decrease of serum glucagon in rats treated with NaF (100 mg
F/1 l) for 1 year (Hu et al. 2012). Summarizing, fluoride af-
fects glucose and insulin levels in a dose and time dependent
fashion—an increase or decrease can be observed. Thus, re-
ported hyperglycemia may derive from an inhibitory effect of
fluoride on the secretion of insulin, via altered intracellular
signaling pathways related to insulin secretion (Menoyo
et al. 2005). This effect was observed when plasma fluoride
concentration was higher than 5 μMafter a single dose of NaF
in rats (7.6 mg F/kg body weight) and in humans (60 mg NaF)
(Rigalli et al. 1990) and also in rats after administration of NaF
(100 ppm) in drinking water for 30 days (Rigalli et al. 1992).
The effect appears not to be related to insulin resistance
(Chehoud et al. 2008), and the effect is absent when rats have
high bone fluoride content, which is consistent with low plas-
ma and tissue fluoride levels (Rigalli et al. 1992).
The brain is highly susceptible to oxidative stress because
of high level of unsaturated fatty acids, high oxygen utiliza-
tion, high iron content, and decreased activities of detoxifying
enzymes (Bharath et al. 2002). Because glucose metabolism
not only fulfills the energy requirement of the brain, but also
provides ribose precursors for synthesis of nucleosides and
NADPH which are necessary for synthesis of lipids and neu-
rotransmitters as well as for the removal of free radicals
(Nehlig 2004), we hypothesize the following Bbiological^ se-
quence relating to fluoride exposure: initially, fluoride alters
brain glucose metabolism which thus impairs energy balance
and free radical clearance.
Despite the apparent direct adverse impact of fluoride on
neuronal viability in the brain, a fluoride compensatory in-
crease in glucose uptake and utilization may partially offset
the neurodegenerative effects by enhancing the neuroprotec-
tive effects and/or regenerative ability of neurons and/or glia.
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